January 27, 2025
Funded Research
About Funded Research
The MRF has funded over $26 million in melanoma research since 1998. Our research grants support the study of melanoma prevention, diagnosis, and treatment across the spectrum of the disease, including cutaneous, ocular, and mucosal melanoma. The MRF Research Program supports research across their entire career- from medical students to established investigators. The MRF Research Program supports research across their entire career- from medical students to established investigators.
Peer Reviewed SAC/BC/OM Grants
Est. in 2014
Team Awards
Two-year Awards
Up to $250,000 per year
Est. in 2006
Established (Senior) Investigator Awards
Two-year Awards
Up to $125,000 Per Year
Est. in 1998
Career Development (Junior) Awards
Two-year Awards
Up to $50,000 Per Year
Est. in 2022
Pilot Awards
One-year Awards
Up to $50,000
Est. in 2024
Resident/Fellow Awards
One-year Awards
Up to $10,000
Est. in 2011
Medical Student Awards
One-year Awards
Up to $3,000
Research Awards
Sponsored by MRF Since 2023
ASCO/Conquer Cancer Endowed Merit Award
One-year Awards
$1,000 Per Year
Sponsored by MRF Since 2013
Society for Melanoma Research Young Investigator Award
One-year Awards
$5,000 per year
Sponsored by MRF Since 2015
Society for Melanoma Research Christopher J. Marshall Award
One-year Awards
$5,000 Per Year
Donor-directed
Donor Awards to Fund Specific Areas of Melanoma Research
Occasionally, we also have special opportunities available that do not adhere to our usual categories.
Discover Funded Researchers
Jaclyn Roland-McGowan
A/B Testing of Patient Decision Aids for Dysplastic Nevi Treatment
Chenxu Shi, MD, PhD
Predictive Biomarkers of Response to Neoadjuvant Immunotherapy in Melanoma
Gabriella Alvarez, MS, MD
Melanoma Incidence, Presentation, and Outcomes in Minorities with Diabetes
Sidharth Chand, AM, MD
Quantitative Digital Assessment of PRAME Expression in Melanoma
Dong Ren, MD, PhD
Molecular Investigation of Metastatic Sinonasal Mucosal Melanoma
Ravi Amaravadi, MD
RNA-LNP Therapeutics for Resistant Melanoma
Kathleen N Klinzing
Regulating Golgi Structure to Improve Melanoma-Reactive T Cell Therapy
Devarati Mitra, MD, PhD
Neoadjuvant immunotherapy and radiotherapy for mucosal melanoma
Haarisudhan Sureshkumar
